HBC Construction Limited (HBC), formerly known as Henry Boot Construction, has begun work on a new cancer centre in Leeds for the UK’s leading independent cancer care provider, GenesisCare. The ...

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, recently acquired Liora Technologies, ...

Cancer immunotherapy has transformed oncology, yet many patients fail to respond or eventually develop resistance.

Doctors in India are increasingly exploring “dose optimisation” to make expensive treatments more affordable while also reducing side-effects, and new findings from Tata Memorial Hospital highlight ...

Radiopharm Theranostics maintains a "Hold" rating as its radiotherapeutic pipeline advances, with key data readouts expected in 2026. Click here to read.

This page contains press release content distributed by XPR Media. Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content. The placement of ...

Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed novel epigenetic immunoactivator GNTbm-38, with global rights for cancer ...

Scientists have experimented with bacteria as potential cancer therapy for a while now — some introduced to trigger an immune ...

The facility will provide a full range of essential cancer treatments including chemotherapy, immunotherapy, and cellular therapy ...

Shortages of cancer drugs, vaccines and other essential medicines in Pakistan raise concerns, with industry sources blaming ...

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help ...

A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told ...